QuidelOrtho Corporation QuidelOrtho Corporation

QuidelOrtho Corporation

QDEL

Classificação em ações #9368
QuidelOrtho Corporation specializes in the creation and production of... QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracking disease progression. The Transfusion Medicine unit focuses on ensuring blood safety and compatibility by offering immunohematology and infectious disease screening tests for blood and plasma. For rapid results in various clinical environments, the Point-of-Care segment delivers quick diagnostic tests. Additionally, the Molecular Diagnostics arm develops advanced polymerase chain reaction thermocyclers, analyzers, and amplification systems. QuidelOrtho distributes its offerings both directly to end-users and through an extensive network of distributors. These products are utilized by professionals in settings such as medical offices, hospitals, clinical and reference laboratories, urgent care centers, universities, retail clinics, pharmacies, wellness screening centers, and blood/donor banks, as well as for individual, non-professional, and over-the-counter applications. Founded in 1979 and based in San Diego, California, the company maintains a global footprint, including operations across North America, Europe, the Middle East, Africa, and China.
Preço da ação
$14.24
Valor de mercado
$976.51M
Variação (1 dia)
11.60%
Variação (1 ano)
-66.95%
País
US
Negociar QuidelOrtho Corporation (QDEL)

Categoria

Healthcare
Lucros da QuidelOrtho Corporation (QDEL)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da QuidelOrtho Corporation, os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da QuidelOrtho Corporation de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
$3.81B -
US
$4.11B -
FR
- -
JP
$1.59B -
US
- -
CH